Compare Stocks

→ Your Money is Not Safe (From American Alternative) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTI British American Tobacco	$29.05 +0.8%	$29.97	$28.25 ▼ $37.65	$71.37B	0.53	4.98 million shs	5.58 million shs
FAB First Trust Multi Cap Value AlphaDEX Fund	$78.44 +1.3%	$79.12	$64.89 ▼ $82.62	$152.95M	0.98	5,682 shs	3,314 shs
LTY Liberty Biopharma	C$2.00 +∞	C$2.00	C$0.06 ▼ C$2.74	C$21.54M	N/A	23,286 shs	700 shs
RENE Cartesian Growth Co. II	$11.18 -0.1%	$11.10	$10.52 ▼ $11.92	$241.71M	-0.01	57,729 shs	95,585 shs

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTI British American Tobacco	+0.82%	-0.98%	-7.26%	-2.22%	-21.11%
FAB First Trust Multi Cap Value AlphaDEX Fund	+0.19%	-2.93%	-2.69%	+2.20%	+10.89%
LTY Liberty Biopharma	0.00%	0.00%	0.00%	0.00%	0.00%
RENE Cartesian Growth Co. II	+0.04%	+0.13%	+0.68%	+1.41%	+6.32%

Your Money is Not Safe (Ad)

Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

CLICK HERE TO GET YOUR GUIDE NOW

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BTI British American Tobacco	1.1914 of 5 stars	0.0	3.0	2.5	0.0	3.0	0.0	1.3
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RENE Cartesian Growth Co. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BTI British American Tobacco	2.67	Moderate Buy	N/A	N/A
FAB First Trust Multi Cap Value AlphaDEX Fund	0.00	N/A	$86.52	10.30% Upside
LTY Liberty Biopharma	N/A	N/A	N/A	N/A
RENE Cartesian Growth Co. II	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BTI British American Tobacco	$33.94B	2.10	$18.99 per share	1.53	$26.80 per share	1.08
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A	N/A	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	N/A	C$0.00 per share	2,000.00	C$0.79 per share	N/A
RENE Cartesian Growth Co. II	N/A	N/A	$0.40 per share	28.09	($0.64) per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BTI British American Tobacco	-$17.87B	N/A	0.00	5.74	1.20	N/A	N/A	N/A	N/A
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A	N/A	11.74	∞	N/A	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	-C$0.16	N/A	∞	N/A	N/A	N/A	N/A	N/A
RENE Cartesian Growth Co. II	$11.44M	N/A	0.00	∞	N/A	N/A	-65.59%	5.02%	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BTI British American Tobacco	$2.93	10.09%	+1.97%	N/A	1 Years
FAB First Trust Multi Cap Value AlphaDEX Fund	$1.48	1.89%	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	N/A	N/A	N/A	N/A
RENE Cartesian Growth Co. II	N/A	N/A	N/A	N/A	N/A

Latest IXI, RENE, LTY, FAB, and BTI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/14/2024	BTI British American Tobacco	quarterly	$0.7431	9.6%	12/20/2024	12/20/2024	2/6/2025
2/13/2024	BTI British American Tobacco	quarterly	$0.7431	9.6%	12/20/2024	12/20/2024	2/6/2025
2/12/2024	BTI British American Tobacco	quarterly	$0.7431	9.5%	6/28/2024	6/28/2024	8/7/2024
2/8/2024	BTI British American Tobacco	Quarterly	$0.7330	9.53%	3/21/2024	3/22/2024	5/7/2024
3/20/2024	FAB First Trust Multi Cap Value AlphaDEX Fund	Quarterly	$0.2430		3/21/2024	3/22/2024	3/28/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BTI British American Tobacco	0.67	0.91	0.59
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A	N/A	N/A
LTY Liberty Biopharma	8.19	0.12	0.12
RENE Cartesian Growth Co. II	N/A	0.22	0.22

Ownership

Institutional Ownership

Company	Institutional Ownership
BTI British American Tobacco	21.44%
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A
LTY Liberty Biopharma	N/A
RENE Cartesian Growth Co. II	58.96%

Insider Ownership

Company	Insider Ownership
BTI British American Tobacco	0.03%
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A
LTY Liberty Biopharma	N/A
RENE Cartesian Growth Co. II	20.00%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BTI British American Tobacco	46,000	2.46 billion	2.46 billion	Optionable
FAB First Trust Multi Cap Value AlphaDEX Fund	147,000	1.95 million	N/A	Not Optionable
LTY Liberty Biopharma	N/A	10.77 million	N/A	Not Optionable
RENE Cartesian Growth Co. II	N/A	21.62 million	17.30 million	Not Optionable

IXI, RENE, LTY, FAB, and BTI Headlines

Source	Headline
	Cartesian Growth Co. II (NASDAQ:RENE) Shares Up 0% americanbankingnews.com - April 19 at 2:58 AM
	Cartesian Growth Co. II (NASDAQ:RENE) Short Interest Update marketbeat.com - March 28 at 8:23 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
5 Stocks in the Current Bull Market with Upside to Come
April 5, 2024 10:14 AM
View 5 Stocks in the Current Bull Market with Upside to Come
5 Top-Rated Dividend Stocks With Double-Digit Upside
March 25, 2024 11:19 AM
View 5 Top-Rated Dividend Stocks With Double-Digit Upside
Silicon Motion Proves That AI in Motion Stays in Motion
April 16, 2024 11:42 AM
View Silicon Motion Proves That AI in Motion Stays in Motion

All Headlines

Company Descriptions

British American Tobacco

NYSE:BTI

British American Tobacco p.l.c. engages in the provision of tobacco and nicotine products to consumers worldwide. It also offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company offers its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Camel, Natural American Spirit, Newport, Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, State Express 555 and Shuang Xi brands. It also distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

First Trust Multi Cap Value AlphaDEX Fund

NASDAQ:FAB

The First Trust Multi Cap Value AlphaDEX Fund (FAB) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Multi Cap Value index. The fund tracks an index that uses fundamental factors to select and weight value stocks from the Nasdaq US Select Indices. FAB was launched on May 8, 2007 and is managed by First Trust.

Liberty Biopharma

CVE:LTY

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

Cartesian Growth Co. II

NASDAQ:RENE

Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial